51672-1376 : Naftifine Hydrochloride 20 mg/g Topical Gel


NDC51672-1376
Labeler: Taro Pharmaceuticals U.S.a., Inc.
Product Type: Human Prescription Drug
Drug Name:  Naftifine Hydrochloride
Dosage Form: Topical Gel
Application #: ANDA208201
Rev. Date: 


NDC Package Codes:

  • 51672-1376-3: 1 TUBE IN 1 CARTON (51672‑1376‑3) > 60 G IN 1 TUBE
  • 51672-1376-6: 1 TUBE IN 1 CARTON (51672‑1376‑6) > 45 G IN 1 TUBE

Active Ingredients:

  • Naftifine Hydrochloride

Dosage Strength:

  • 20 mg/g

Pharmaceutical Classes:

  • Allylamine [CS]
  • Allylamine Antifungal [EPC]

Related Products:

Based on records with the same trade name.
  • 51672-1362 Naftifine Hydrochloride 10 mg/g Topical Cream by Taro Pharmaceuticals U.S.a., Inc.
  • 51672-1368 Naftifine Hydrochloride 20 mg/g Topical Cream by Taro Pharmaceuticals U.S.a., Inc.
  • 0115-1510 Naftifine Hydrochloride 10 mg/g Topical Gel by Amneal Pharmaceuticals of New York LLC
  • 0115-1512 Naftifine Hydrochloride 20 mg/g Topical Cream by Impax Generics
  • 40085-201 Naftifine Hydrochloride 1 mg/g Topical Cream by Renaissance Pharma, Inc
  • 40085-203 Naftifine Hydrochloride 20 mg/g Topical Cream by Renaissance Pharma, Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 51672-1376 QR Code

< Prev: 51672-1374Next: 51672-1377 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 10 May 2019.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA